Expression, prognostic and predictive impact of VEGF and bFGF in non-small cell lung cancer

被引：64
作者：
Farhat, Fadi S. [2 ]
Tfayli, Arafat [3 ]
Fakhruddin, Najla [5 ]
Mahfouz, Rami [4 ]
Otrock, Zaher K. [3 ]
Alameddine, Raafat S. [3 ,6 ]
Awada, Ahmad H. [1 ]
Shamseddine, Ali [3 ,7 ]
机构：
[1] Univ Libre Bruxelles, Inst Jules Bordet, Med Oncol Clin, B-1000 Brussels, Belgium
[2] Hammoud Hosp Univ Med Ctr, Dept Hematol Oncol, Saida, Lebanon
[3] Amer Univ Beirut, Med Ctr, Dept Internal Med, Beirut, Lebanon
[4] Amer Univ Beirut, Med Ctr, Dept Pathol & Lab Med, Fac Med, Beirut, Lebanon
[5] Hammoud Hosp Univ Med Ctr, Dept Pathol, Saida, Lebanon
[6] Amer Univ Beirut, Nayef K Basil Canc Ctr, Beirut, Lebanon
[7] Amer Univ Beirut, Div Hematol Oncol, Beirut, Lebanon
来源：
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | 2012年 / 84卷 / 02期
关键词：
Non-small cell lung cancer; VEGF; bFGF; Angiogenic markers; Expression; Prognostic impact; Review; ENDOTHELIAL GROWTH-FACTOR; VASCULAR-PERMEABILITY FACTOR; FACTOR MESSENGER-RNA; RANDOMIZED PHASE-II; INCREASED SERUM-LEVELS; TUMOR ANGIOGENESIS; FACTOR-C; CLINICAL-SIGNIFICANCE; LYMPHATIC VESSELS; FACTOR FAMILY;
D O I：
10.1016/j.critrevonc.2012.02.012
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Despite major advances in cancer therapeutics, the prognosis for lung cancer patients is still poor and the median survival for patients presenting with advanced non-small cell lung cancer (NSCLC) is only 8-10 months. Angiogenesis is an important biological process and a relatively early event during lung cancer pathogenesis. Anti-angiogenic agents are used in treating patients with NSCLC, and their molecular biomarkers are also being assessed to predict response. A better understanding of the biology of angiogenesis in NSCLC may reveal new targets for treating this malignancy. In this article, we review the expression and prognostic impact of the angiogenic growth factors, vascular endothelial growth factor and basic fibroblast growth factor, in NSCLC. (C) 2012 Published by Elsevier Ireland Ltd.
引用
收藏
页码：149 / 160
页数：12
相关论文
共 119 条
  • [71] Vegfb gene knockout mice display reduced pathology and synovial angiogenesis in both antigen-induced and collagen-induced models of arthritis
    Mould, AW
    Tonks, ID
    Cahill, MM
    Pettit, AR
    Thomas, R
    Hayward, NK
    Kay, GF
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : 2660 - 2669
  • [72] Histopathologic and genetic alterations as predictors of response to treatment and survival in lung cancer: A review of published data
    Mountzios, Giannis
    Dimopoulos, Meletios-Athanassios
    Soria, Jean-Charles
    Sanoudou, Despina
    Papadimitriou, Christos A.
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2010, 75 (02) : 94 - 109
  • [73] Nakashima T, 2004, MED SCI MONITOR, V10, pBR157
  • [74] The biology of vascular endothelial growth factor-B (VEGF-B)
    Nash, AD
    Baca, M
    Wright, C
    Scotney, PD
    [J]. PULMONARY PHARMACOLOGY & THERAPEUTICS, 2006, 19 (01) : 61 - 69
  • [75] Vandetanib Versus Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer: Results From a Two-Part, Double-Blind, Randomized Phase II Study
    Natale, Ronald B.
    Bodkin, David
    Govindan, Ramaswamy
    Sleckman, Bethany G.
    Rizvi, Naiyer A.
    Capo, Adolfo
    Germonpre, Paul
    Eberhardt, Wilfried E. E.
    Stockman, Paul K.
    Kennedy, Sarah J.
    Ranson, Malcolm
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15) : 2523 - 2529
  • [76] Vascular endothelial growth factor (VEGF) and its receptors
    Neufeld, G
    Cohen, T
    Gengrinovitch, S
    Poltorak, Z
    [J]. FASEB JOURNAL, 1999, 13 (01) : 9 - 22
  • [77] ELEVATED LEVELS OF AN ANGIOGENIC PEPTIDE, BASIC FIBROBLAST GROWTH-FACTOR, IN THE URINE OF PATIENTS WITH A WIDE SPECTRUM OF CANCERS
    NGUYEN, M
    WATANABE, H
    BUDSON, AE
    RICHIE, JP
    HAYES, DF
    FOLKMAN, J
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (05) : 356 - 361
  • [78] Plasma Cytokine and Angiogenic Factor Profiling Identifies Markers Associated with Tumor Shrinkage in Early-Stage Non-Small Cell Lung Cancer Patients Treated with Pazopanib
    Nikolinakos, Petros G.
    Altorki, Nasser
    Yankelevitz, David
    Tran, Hai T.
    Yan, Shaoyu
    Rajagopalan, Dilip
    Bordogna, Walter
    Ottesen, Lone H.
    Heymach, John V.
    [J]. CANCER RESEARCH, 2010, 70 (06) : 2171 - 2179
  • [79] Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small cell lung cancer
    O'Byrne, KJ
    Koukourakis, MI
    Giatromanolaki, A
    Cox, G
    Turley, H
    Steward, WP
    Gatter, K
    Harris, AL
    [J]. BRITISH JOURNAL OF CANCER, 2000, 82 (08) : 1427 - 1432
  • [80] Ohta Y, 2007, J EXP CLIN CANC RES, V26, P301
3456789101112